Literature DB >> 3108353

Prevention of oxygen toxicity with superoxide dismutase and catalase in premature lambs.

F J Walther, C E Gidding, I M Kuipers, D Willebrand, E M Bevers, A Abuchowski, A T Viau.   

Abstract

The use of high oxygen concentrations and high mean airway pressures during mechanical ventilation of premature newborn infants with respiratory distress syndrome leads in 20%-30% of the survivors to chronic lung disease. This study explores if exogenous polyethylene glycol conjugated superoxide dismutase (PEG-SOD) and catalase (PEG-CAT) mitigate oxygen toxicity in premature lambs with respiratory distress syndrome. Six pairs of premature lambs were delivered by cesarean section and treated by tracheal instillation of 60 mg natural sheep surfactant/kg/body weight. After birth, all lambs were ventilated with 100% oxygen, and one of each pair received a single intravenous injection of 1 million U/kg PEG-CAT and 50,000 U/kg PEG-SOD. At 8 h of age or after respiratory failure was established, the lambs were killed and the lungs were removed intact. Lung damage was assessed by microscopy. The arterial blood gases, pH, and mean airway pressures of the lambs treated with PEG-SOD/PEG-CAT did not differ from those of the controls. Mean PaO2 was greater than 140 mmHg during the first 4 h of the experiments. In the lambs treated with PEG-SOD/PEG-CAT, SOD and CAT levels were very high during the study period and less bronchiolar epithelial damage and lung hemorrhages were found at microscopy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3108353     DOI: 10.1016/s0748-5514(86)80012-5

Source DB:  PubMed          Journal:  J Free Radic Biol Med        ISSN: 0748-5514


  1 in total

1.  Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse.

Authors:  Mitchell Machtay; Arnaud Scherpereel; José Santiago; James Lee; Jim McDonough; Paul Kinniry; Evguenia Arguiri; Vladimir V Shuvaev; Jing Sun; Keith Cengel; Charalambos C Solomides; Melpo Christofidou-Solomidou
Journal:  Radiother Oncol       Date:  2006-10-27       Impact factor: 6.280

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.